Armstrong: Next Five Years Will Transform Venture More Than Any Past Era
Brian Armstrong · Healthcare Innovation and Venture Capital with Brian Armstrong of Ensemble Innovation Ventures · Sep 22, 2025 · at 34:53
Brian Armstrong, Managing Director at Ensemble Innovation Ventures, discusses the compounding effects of AI adoption, fund restructuring, and macro rates on venture capital.
0:00 / 0:09exact quote · 9.4s
720p mp4 · rendered on demand · StarZero watermark
“The next five year period, if we just looked at the history of venture, the next five years are going to change venture more than any five year period in the history of venture.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Brian Armstrong
Armstrong: Corporate VC funds need dedicated capital and clear deployment timelines
“Really any full corporate venture fund or hybrid corporate venture fund needs to know what its dedicated capital is just like a traditional venture fund. It's just, Important because as you're deploying dry powder you want to know what the, you know, what kind…”
Armstrong: CVCs cannot offer deep strategic support to every portfolio company
“You can't be, you can't support every single portfolio company in some kind of deep strategic way because you'd be a mile wide and an inch deep, and you would really overburden and over tax your operating company partners who are really the ones ultimately who…”
Armstrong: Many Established VC Funds Are Announcing They Won't Raise Next Funds
“And I think the other thing we've seen is a lot of established funds have announced that they are not going to raise a next fund.”
Armstrong: Ensemble puts 75% of first checks into Series A and 25% into Seed
“We typically focus on series A rounds. That's kind of our sweet spot. So about 75% of our first checks Go into A rounds and about 25% of our checks go into seed rounds.”
Armstrong: Ensemble seeks $1.5M-$2M ARR for Series A, $750K-$1.5M for Seed
“For the A rounds, we do like to see companies that are, you know, doing a million and a half to two million of annualized run rate at the minimum and up from there. And then for our seed stage investments, we love to see companies that are post revenue but ear…”